RxDoctor Payments Data

Barry Seidman, MD

Internal Medicine · Delray Beach, FLNPI 1730142951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,379 and has fallen 83.4% since, to $229 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,587in general payments, 2019–2025

Across 60 payments — averaging $109.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$767
  • Esperion Therapeutics, Inc.$761
  • Johnson & Johnson$556
  • Atricure, Inc.$505
  • Abbott$504
  • Novo Nordisk$429
  • plus $3K from 17 others
$227,081in research payments, 2019–2025

Across 49 payments — averaging $4634.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$227K

What the payments were for

  • Food & beverage$6,587100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,587 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$43,942
Medicare patients
97
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium93$1,182
Ezetimibe11$564
Levothyroxine Sodium28$345
Metformin Hcl35$164
Famotidine12$137
Amlodipine Besylate14$120
Lisinopril14$113
Pantoprazole Sodium12$108
Atorvastatin Calcium17$32
Hydrochlorothiazide14$17

Paid to pharmacies, not to this prescriber.

Other internal medicine in Delray Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →